Clinical Biocompatibility Evaluation of Contact Lens Coatings
Not Applicable
Completed
- Conditions
- Refractive ErrorsAmetropia
- Interventions
- Device: Contact lens with investigational coating 1Device: Balafilcon A contact lensDevice: OPTI-FREE® RepleniSH® MPDSDevice: Contact lens with investigational coating 2
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 33
- Registration Number
- NCT03034928
- Locations
- 🇺🇸
Alcon Investigative Site, Johns Creek, Georgia, United States
Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction
Not Applicable
Completed
- Conditions
- Refractive Error - Myopia SevereRefractive Error - Myopia Simple
- Interventions
- Device: WaveLight® Ultraviolet Femtosecond (FS) Laser SystemProcedure: Laser Assisted Lenticular Extraction
- First Posted Date
- 2017-01-16
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 7
- Registration Number
- NCT03021707
- Locations
- 🇸🇬
Alcon Investigative Site, Singapore, Singapore
A Clinical Study of the ACRYSOF® IQ EDF Intraocular Lens (IOL)
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: ACRYSOF® IQ Monofocal IOLDevice: ACRYSOF® IQ Extended Depth of Focus IOLProcedure: Cataract surgery
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 322
- Registration Number
- NCT03010254
- Locations
- 🇬🇧
Alcon Investigative Site, Manchester, United Kingdom
Optimizing the Assessment of Refractive Outcomes After Cataract Surgery
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Procedure: Manifest refractionDevice: ACRYSOF® IQ Monofocal IOL Model SN60WFDevice: Topcon® KR-1W Wave-Front Analyzer
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 162
- Registration Number
- NCT02842151
Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
Not Applicable
Completed
- Conditions
- Cataracts
- Interventions
- Device: Monarch III D Manual IOL Delivery SystemDevice: iTec Preloaded Delivery SystemDevice: iSert Preloaded Delivery SystemDevice: UltraSert Preloaded Delivery System
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 114
- Registration Number
- NCT02826421
Clinical Outcomes Following Treatment With SYSTANE® BALANCE
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Propylene glycol, 0.6% eye dropsOther: Lubricant eye drops
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 308
- Registration Number
- NCT02776670
24-hr Intraocular Pressure Control With SIMBRINZA ®
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 162
- Registration Number
- NCT02770248
Clinical Evaluation of the Safety and Efficacy of FID 120947A
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: FID 120947A contact lens disinfecting solutionDevice: Soft contact lenses (SCL)Device: SCL preservative solution
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 91
- Registration Number
- NCT02771145
- Locations
- 🇯🇵
Contact Alcon Japan, Ltd. for Trial Locations, Tokyo, Japan
A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
Phase 1
Completed
- Conditions
- Ocular HypertensionOpen-Angle Glaucoma
- Interventions
- Drug: MGV354 ophthalmic suspensionDrug: MGV354 placebo
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 191
- Registration Number
- NCT02743780
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
Phase 4
Terminated
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- Drug: Brinzolamide/brimonidine vehicle
- First Posted Date
- 2016-04-07
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 173
- Registration Number
- NCT02730871
- Locations
- 🇺🇸
Contact Alcon for Locations (Europe, Asia, and Latin America), Fort Worth, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath